drugset / Trial / NCT00575016
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to explore the effectiveness and safety of several doses of botulinum toxin type A in treating overactive bladder in patients with spinal cord injury.
Timeline
- Start
- 2007-12
- Primary completion
- 2010-02
- Completion
- 2010-07
Outcome
Outcome not reported
Stopped (Enrollment): “The study was terminated early due to enrollment challenges.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |